New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 16, 2014
10:08 EDTAET, WLP, UNH, HUMUnitedHealth retreats after Citi cuts rating on shares
Shares of health insurer UnitedHealth (UNH) are dropping slightly in an advancing market after Citigroup downgraded the stock in a note to investors earlier today. WHAT'S NEW: United Health's stock doesn't justify a Buy rating at current levels, Citigroup analyst Carl McDonald wrote. The company has limited opportunities to increase its profits this year and its clients may utilize more health services, McDonald contends. Additionally, UnitedHealth spent a greater percentage of its revenues from Medicaid on medical expenses in the fourth quarter versus the previous quarter, the analyst noted. McDonald downgraded UnitedHealth to Neutral from Buy, but increased his price target on the stock to $79 from $77. PRICE ACTION: In early trading, UnitedHealth fell about 1% to $78.67. Other health insurers also declined, with Aetna (AET) giving back 0.5% to $71.25, Humana (HUM) losing 0.5% to $109.15, and WellPoint (WLP) declining 0.4% to $96.06.
News For UNH;AET;HUM;WLP From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 26, 2014
07:08 EDTUNHUnitedHealth to host investor conference
Subscribe for More Information
November 21, 2014
16:36 EDTAETMarket ends week higher as domestic data, foreign central banks boost shares
Subscribe for More Information
14:27 EDTAETAetna raises quarterly dividend 11%, authorizes additional $1B share buyback
Subscribe for More Information
14:26 EDTAETAetna raises quarterly dividend 11%, authorizes additional $1B share buyback
Subscribe for More Information
November 17, 2014
14:06 EDTHUMHumana to offer plans on 15 state ACA individual market exchanges in 2015
Subscribe for More Information
07:16 EDTAETMilken Institute--Faster Cures to hold a conference
Subscribe for More Information
November 14, 2014
08:04 EDTWLPWellPoint, Boehringer Ingelheim announce first project under collaboration
Boehringer Ingelheim Pharmaceuticals, WellPoint and HealthCore, announced that the companies are commencing a research project to identify and address unmet medical needs across populations of mutual interest. The first stage of the project will focus on non-valvular atrial fibrillation and will examine disease prevalence, treatment complications, such as hospital readmissions, and the use of evidence-based guidelines. This project is the first under the parties’ five-year research collaboration agreement, signed earlier this year. Information gathered through the NVAF project is intended to provide the basis for the collaborative development of healthcare interventions, which can be evaluated within WellPoint’s affiliated health plans and provider networks.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use